Detalhe da pesquisa
1.
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs.
Int J Mol Sci
; 24(10)2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240037
2.
Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life. / Prevalencia de déficit de hierro sin anemia en la enfermedad inflamatoria intestinal y su impacto en la calidad de vida.
Gastroenterol Hepatol
; 41(1): 22-29, 2018 Jan.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-28899570
3.
Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission. / Evolución tras el intercambio a infliximab biosimilar en pacientes con enfermedad inflamatoria intestinal en remisión clínica.
Gastroenterol Hepatol
; 40(9): 595-604, 2017 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-28865888
4.
Prevalencia de déficit de hierro sin anemia en la enfermedad inflamatoria intestinal y su impacto en la calidad de vida / Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life
Gastroenterol. hepatol. (Ed. impr.)
; 41(1): 22-29, ene. 2018. tab, graf
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-170242
5.
Evolución tras el intercambio a infliximab biosimilar en pacientes con enfermedad inflamatoria intestinal en remisión clínica / Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission
Gastroenterol. hepatol. (Ed. impr.)
; 40(9): 595-604, nov. 2017. graf, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-168184